Vestmark Advisory Solutions’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Vestmark Advisory Solutions’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$307K	Sell	9,069 -15,205	-63%	-$506K	﹤0.01%	1261
2026 Q1	$731K	Buy	+24,274	New	+$781K	0.01%	957

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $21.3B AUM 44.31% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.8B AUM 42.86% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $59.1B AUM 41.96% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $20.7B AUM 58.31% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $16.3B AUM 54.64% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $5.74B AUM 42.24% 1-Year Est. Return

Vestmark Advisory Solutions's TEVA Position: Q2 2026 in Review

Vestmark Advisory Solutions reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 63% in Q2 2026, selling an estimated $506K and leaving 9,069 shares worth $307K. The position accounts for ﹤0.01% of the portfolio, ranked #1261.

Vestmark Advisory Solutions first reported a position in TEVA in Q1 2026 and has held it in 2 quarters since. The position peaked at $731K in Q1 2026. 679 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Vestmark Advisory Solutions held 9,069 shares of Teva Pharmaceutical Industries Limited worth $307K as of Q2 2026.
Vestmark Advisory Solutions sold 15,205 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $506K.
Teva Pharmaceutical Industries Limited made up ﹤0.01% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #1261 holding.
Vestmark Advisory Solutions first reported a position in Teva Pharmaceutical Industries Limited in Q1 2026 and has held it in 2 quarters since.
Vestmark Advisory Solutions's Teva Pharmaceutical Industries Limited position peaked at $731K in Q1 2026.
679 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.